NEFL and Parkinson disease: NFL in CSF or plasma has high sensitivity, and changes its levels become evident before clinical symptoms of neurodegeneration, increasing in various neurodegenerative diseases, such as AD, amyotrophic lateral sclerosis, spinal muscular atrophy, multiple sclerosis, and Parkinson’s disease (PD) [84].